Shopping Cart
Remove All
Your shopping cart is currently empty
Flunarizine is an orally administered peripheral vasodilator, acting as a dual blocker of voltage-gated Na+/Ca2+ channels and a D2 dopamine receptor antagonist, exhibiting anti-migraine activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $30 | - | In Stock | |
| 50 mg | $42 | - | In Stock | |
| 100 mg | $59 | - | In Stock | |
| 200 mg | $85 | - | In Stock |
| Description | Flunarizine is an orally administered peripheral vasodilator, acting as a dual blocker of voltage-gated Na+/Ca2+ channels and a D2 dopamine receptor antagonist, exhibiting anti-migraine activity. |
| In vitro | In cultured rat cortical neurons, Flunarizine blocks sodium current (INa) and calcium current (ICa), with half-maximal inhibitory concentrations (IC50) of 0.94 μM and 1.77 μM, respectively [2]. Flunarizine (concentrations 10 μM, 30 μM; exposure time 24 hours) exhibits cytotoxic effects on chromaffin cells [4]. Within the concentration range of 3-10 μM, Flunarizine demonstrates significant cytoprotective effects on chromaffin cells [4]. |
| In vivo | In a lipopolysaccharide (LPS)-induced acute lung injury (ALI) mouse model, preventive administration of Flunarizine (30 mg/kg, intraperitoneal injection) significantly inhibited LPS-induced cell infiltration, protein leakage, and inflammatory cytokine release. Therapeutic administration of flunarizine (30 mg/kg, intraperitoneal injection) also suppressed pulmonary inflammation, but its efficacy was weaker than that of preventive administration [5]. |
| Synonyms | Sibelium, Flunarizinum, Flunarizina, Flunarizin |
| Molecular Weight | 404.50 |
| Formula | C26H26F2N2 |
| Cas No. | 52468-60-7 |
| Relative Density. | 1.170 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (197.78 mM), Sonication is recommended. H2O: Insoluble | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (8.16 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.